98 related articles for article (PubMed ID: 21083450)
1. Therapeutic approaches to non-Hodgkin's lymphoma in the elderly patient.
Ninan MJ; Morrison VA
Expert Rev Hematol; 2009 Apr; 2(2):173-82. PubMed ID: 21083450
[TBL] [Abstract][Full Text] [Related]
2. European experiences on aggressive non-Hodgkin's lymphoma in elderly patients.
Fratino L; Bernardi D
Crit Rev Oncol Hematol; 2004 Sep; 51(3):229-40. PubMed ID: 15331080
[TBL] [Abstract][Full Text] [Related]
3. Non-Hodgkin's lymphoma in the elderly: the impact of advanced age on therapeutic options and clinical results.
Orlandi E; Lazzarino M; Brusamolino E; Castelli G; Pagnucco G; Morra E; Bernasconi C
Haematologica; 1991; 76(3):204-8. PubMed ID: 1743590
[TBL] [Abstract][Full Text] [Related]
4. Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
van Imhoff GW; van der Holt B; Mackenzie MA; Van't Veer MB; Wijermans PW; Ossenkoppele GJ; Schouten HC; Sonneveld P; Steijaert MM; Kluin PM; Kluin-Nelemans HC; Verdonck LF;
J Clin Oncol; 2005 Jun; 23(16):3793-801. PubMed ID: 15809447
[TBL] [Abstract][Full Text] [Related]
5. Non-Hodgkin's lymphoma in the elderly. Part 1: Overview and treatment of follicular lymphoma.
Morrison VA
Oncology (Williston Park); 2007 Aug; 21(9):1104-10. PubMed ID: 17910313
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
7. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
8. [Non-Hodgkin lymphoma in the elderly].
Dupuis J; Haioun C
Bull Cancer; 2008 May; 95 FMC Onco():F79-83. PubMed ID: 18511372
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
[TBL] [Abstract][Full Text] [Related]
10. Primary localized stages I and II non-Hodgkin's lymphoma of the nasopharynx: a retrospective 17-year single institutional experience.
Mohammadianpanah M; Ahmadloo N; Mozaffari MA; Mosleh-Shirazi MA; Omidvari S; Mosalaei A
Ann Hematol; 2009 May; 88(5):441-7. PubMed ID: 18931844
[TBL] [Abstract][Full Text] [Related]
11. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
12. [Recent progress in the treatment of malignant lymphoma].
Ogura M
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1213-35. PubMed ID: 11579632
[TBL] [Abstract][Full Text] [Related]
13. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
14. Current approaches to the management of non-Hodgkin's lymphoma.
Vose JM
Semin Oncol; 1998 Aug; 25(4):483-91. PubMed ID: 9728598
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
16. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
Kamieńska E
Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
18. Non-Hodgkin's lymphoma in the elderly. A review with emphasis on elderly patients, geriatric assessment, and future perspectives.
Maartense E; Kluin-Nelemans HC; Noordijk EM
Ann Hematol; 2003 Nov; 82(11):661-70. PubMed ID: 12923662
[TBL] [Abstract][Full Text] [Related]
19. [Survival of patients with aggressive non-hodgkin's lymphoma: no difference between first line treatment in a prospective randomised phase III clinical trial and first line treatment according to routine clinical practice].
van Agthoven M; Wittebol S; Budel LM; Uyl-de Groot CA; Kramer MH
Ned Tijdschr Geneeskd; 2004 Jan; 148(2):88-93. PubMed ID: 14753131
[TBL] [Abstract][Full Text] [Related]
20. [Primary cerebral non-Hodgkin lymphoma in non-immunocompromised subjects].
Blay JY
Bull Cancer; 1997 Oct; 84(10):976-80. PubMed ID: 9435800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]